4241 - 4250 of 6420 Results
Title
Year
-
OPENTitle: Rapid motor progression of Parkinson’s disease associates with clinical and genetic variantsJournal Name: Frontiers in Bioscience-LandmarkPublisher: IMR PressVol: 26Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.52586/5044Best OA location URL: https://www.imrpress.com/journal/FBL/26/12/10.52586/5044/pdfCitation Count: 9
-
OPENTitle: Restriction of Access to Deep Brain Stimulation for Refractory OCD: Failure to Apply the Federal Parity ActJournal Name: Frontiers in PsychiatryPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fpsyt.2021.706181Best OA location URL: https://www.frontiersin.org/articles/10.3389/fpsyt.2021.706181/pdfCitation Count: 17
-
OPENTitle: Cognitive Decline in Parkinson’s Disease: A Subgroup of Extreme Decliners Revealed by a Data-Driven Analysis of Longitudinal ProgressionJournal Name: Frontiers in PsychologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fpsyg.2021.729755Best OA location URL: https://www.frontiersin.org/articles/10.3389/fpsyg.2021.729755/pdfCitation Count: 9
-
OPENTitle: Cell-Type Specific Changes in DNA Methylation of SNCA Intron 1 in Synucleinopathy BrainsJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2021.652226Best OA location URL: https://doi.org/10.3389/fnins.2021.652226Citation Count: 14
-
OPENTitle: Cellular Bioenergetics and AMPK and TORC1 Signalling in Blood Lymphoblasts Are Biomarkers of Clinical Status in FMR1 Premutation CarriersJournal Name: Frontiers in PsychiatryPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fpsyt.2021.747268Best OA location URL: https://escholarship.org/uc/item/8t9256vrCitation Count: 5
-
OPENTitle: Hoehn and Yahr Stage and Striatal Dat-SPECT Uptake Are Predictors of Parkinson’s Disease Motor ProgressionJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2021.765765Best OA location URL: https://escholarship.org/uc/item/6bh4v1crCitation Count: 12
-
OPENTitle: Continuous Subcutaneous Levodopa Delivery for Parkinson’s Disease: A Randomized StudyJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 1Start Page: 177End Page: 186Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-202285Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd202285?id=journal-of-parkinsons-disease%2Fjpd202285Citation Count: 49
-
OPENTitle: Basal Synaptic Transmission and Long-Term Plasticity at CA3-CA1 Synapses Are Unaffected in Young Adult PINK1-Deficient RatsJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2021.655901Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2021.655901/pdfCitation Count: 2
-
OPENTitle: Abnormal Topological Network in Parkinson’s Disease With Impulse Control Disorders: A Resting-State Functional Magnetic Resonance Imaging StudyJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2021.651710Best OA location URL: https://doi.org/10.3389/fnins.2021.651710Citation Count: 3
-
OPENTitle: A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline DataJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.705407Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.705407/pdfCitation Count: 67